Year To Quarter End Consolidated Statement Of Income

TORII PHARMACEUTICAL CO., LTD. - Filing #7340452

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
13,451,000,000 JPY
11,811,000,000 JPY
Cost of sales
7,487,000,000 JPY
6,288,000,000 JPY
Gross profit (loss)
5,963,000,000 JPY
5,522,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
4,580,000,000 JPY
5,960,000,000 JPY
Operating profit (loss)
1,383,000,000 JPY
-437,000,000 JPY
Non-operating income
Interest income
75,000,000 JPY
62,000,000 JPY
Dividend income
JPY
1,000,000 JPY
Non-operating income
83,000,000 JPY
70,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Non-operating expenses
300,000,000 JPY
37,000,000 JPY
Ordinary profit (loss)
1,166,000,000 JPY
-404,000,000 JPY
Extraordinary losses
Extraordinary losses
6,000,000 JPY
1,000,000 JPY
Profit (loss) before income taxes
1,160,000,000 JPY
-405,000,000 JPY
Income taxes
281,000,000 JPY
-116,000,000 JPY
Profit (loss)
878,000,000 JPY
-288,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.